Identification of a metabolic gene panel to predict the prognosis of myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is clonal disease featured by ineffective haematopoiesis and potential progression into acute myeloid leukaemia (AML). At present, the risk stratification and prognosis of MDS need to be further optimized. A prognostic model was constructed by the least absolute shrink...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Fang, Chen, Si‐liang, Dai, Yu‐jun, Wang, Yun, Qin, Zhe‐yuan, Li, Huan, Shu, Ling‐ling, Li, Jin‐yuan, Huang, Han‐ying, Liang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294120/
https://www.ncbi.nlm.nih.gov/pubmed/32337851
http://dx.doi.org/10.1111/jcmm.15283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294120/
https://www.ncbi.nlm.nih.gov/pubmed/32337851
http://dx.doi.org/10.1111/jcmm.15283

Ejemplares similares